Valneva SE (VALN) Interest Expenses (2021 - 2026)

Valneva SE's (VALN) quarterly Interest Expenses came in at -$6.0 million in Q1 2026, up 5.21% year-on-year from -$5.7 million in Q1 2025, and down 120.82% quarter-over-quarter from $28.6 million in Q4 2025.

Valneva SE (VALN) Interest Expenses (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Interest Expenses across 6 years of filings, most recently posting -$6.0 million for Q1 2026.

  • Interest Expenses for Q1 2026 came in at -$6.0 million, up 5.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.1 million (up 80.7% YoY), and the FY2025 annual result was $48.8 million, up 90.18% from the prior year.
  • Interest Expenses came in at -$6.0 million for Q1 2026 at Valneva SE, down from $28.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $38.5 million in Q4 2023 to a low of -$7.7 million in Q1 2024.
  • The 5-year median for Interest Expenses is -$4.1 million (2023), against an average of $6.7 million.
  • Peak annual rise in Interest Expenses reached 932.23% in 2024, while the deepest fall reached 82.52% in 2024.
  • Valneva SE's Interest Expenses stood at $33.1 million in 2022, then grew by 16.36% to $38.5 million in 2023, then tumbled by 82.52% to $6.7 million in 2024, then soared by 325.35% to $28.6 million in 2025, then tumbled by 120.82% to -$6.0 million in 2026.
  • The last three Interest Expenses figures came in at -$6.0 million (Q1 2026), $28.6 million (Q4 2025), and $33.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 61,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -332,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -2,753.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -5.58 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -5.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.96 Mn
Mar 31, 2026 -5.96 Mn
Dec 31, 2025 28.64 Mn
Dec 31, 2025 28.64 Mn
Sep 30, 2025 33.77 Mn
Sep 30, 2025 33.77 Mn
Jun 30, 2025 -6.35 Mn
Jun 30, 2025 -6.35 Mn
Mar 31, 2025 -6.29 Mn
Mar 31, 2025 -6.29 Mn
Dec 31, 2024 6.73 Mn
Dec 31, 2024 6.73 Mn
Sep 30, 2024 32.60 Mn
Sep 30, 2024 32.60 Mn
Jun 30, 2024 -5.32 Mn
Jun 30, 2024 -5.32 Mn
Mar 31, 2024 -7.65 Mn
Mar 31, 2024 -7.65 Mn
Dec 31, 2023 38.52 Mn
Dec 31, 2023 38.52 Mn